Form D — Ashvattha Therapeutics SPV Jun 2025 a Series of CGF2021 LLC
0002077741-25-000001 · filed 2025-07-21
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.1
- Total offering
- $170,000
- Total sold
- $170,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ashvattha Therapeutics SPV Jun 2025 a Series of CGF2021 LLC
- CIK
- 2077741
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 2093 PHILADELPHIA PIKE
CLAYMONT, DE 19703 - Phone
- (360) 946-0604
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
LLC Sydecar · DirectorClaymont, DE Find on LinkedIn ↗
-
Brett Sagan · Executive OfficerClaymont, DE Find on LinkedIn ↗
View original on SEC EDGAR.